Moreover, pharmacological inhibition or genetic ablation of HO-1 worsens muscular dystrophy while, in contrast, pharmacological induction of HO-1 improves the phenotype of mdx mice [128,129]. The gene discussed is HMOX1; the disease is muscular dystrophy.